Floyd 2022 Lancet: Difference between revisions
(Created page with "{{Publication |title=Floyd L, Stauss M, Woywodt A (2022) Is open access a misnomer?. Lancet 399:P1226. https://doi.org/10.1016/S0140-6736(22)00107-6. |info=[https://www.thelan...") ย |
No edit summary |
||
Line 8: | Line 8: | ||
|editor=Gnaiger E | |editor=Gnaiger E | ||
}} | }} | ||
== Links == | |||
::::* [[Open Access]] | |||
::::* [[Paywall journalism]] | |||
{{Labeling | {{Labeling | ||
|additional=BEC | |additional=BEC | ||
}} | }} | ||
Revision as of 21:28, 25 March 2022
Floyd L, Stauss M, Woywodt A (2022) Is open access a misnomer?. Lancet 399:P1226. https://doi.org/10.1016/S0140-6736(22)00107-6. |
ยป Open Access
Floyd L, Stauss M, Woywodt A (2022) Lancet
Abstract: As a group of clinicians, we voice our concerns about recent changes to publication fees. Having coauthored an original article together, we were faced with the dilemma of having to pay ยฃ2000 in publication fees. This contrasts with a situation only 2 years ago when publication in most journals was free of charge or only incurred a small administration fee. The situation was further compounded by the fact that these costs are similar across the major journals in our specialty (appendix). Our institution has no dedicated funds to cover publication fees, and we were faced with either having to pay ourselves or retracting the manuscript. It was later agreed that our department would cover the costs on a compassionate basis.
โข Bioblast editor: Gnaiger E
Links
Labels:
BEC